Peer-reviewedCC BYFrontiers in immunology
The hormone–microbiota–NET framework in gynecologic diseases: evidence, controversies, and translational opportunities
- 1College of Basic Medicine, Heilongjiang University of Chinese Medicine , , ,
- 2Department of Chinese Language and Literature, Faculty of Arts, Hong Kong Baptist University , ,
- 3First Clinical Medical College, Heilongjiang University of Chinese Medicine , , ,
Related
- Clinical trial landscape and translational priorities for adoptive T-cell and NK-cell therapies in gynecologic malignancies
- Antigen-Presentation Competence in Gynecologic Cancers: Mechanisms, Evidence and Translational Priorities.
- Trained immunity in cancer immunotherapy and vaccine development: mechanisms, evidence gaps, and translational opportunities
- EEG in Parkinson’s Disease: Mechanisms, Biomarkers and Translational Opportunities
- The Gut Virome in Gastrointestinal Cancers: Mechanisms, Biomarkers, and Translational Opportunities.
BibTeX
@article{xu2026hormonemicrobiotanet,
title = {{The hormone–microbiota–NET framework in gynecologic diseases: evidence, controversies, and translational opportunities}},
author = {Huimin Xu and Tan Jiang and Muxi Li and Deyou Jiang},
journal = {Frontiers in immunology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13656037},
note = {CC BY},
}
RIS
TY - JOUR
TI - The hormone–microbiota–NET framework in gynecologic diseases: evidence, controversies, and translational opportunities
AU - Huimin Xu
AU - Tan Jiang
AU - Muxi Li
AU - Deyou Jiang
PY - 2026
DA - 2026/10/16
JO - Frontiers in immunology
UR - https://europepmc.org/article/PMC/PMC13656037
SN - 1664-3224
ER -